Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Type

Journal article

Journal

J rheumatol

Publication Date

05/2006

Volume

33

Pages

831 - 833

Keywords

Adalimumab, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Arthritis, Rheumatoid, Clinical Trials as Topic, Drug-Related Side Effects and Adverse Reactions, Etanercept, Humans, Immunoglobulin G, Infliximab, Longitudinal Studies, Receptors, Tumor Necrosis Factor, Risk, Time Factors, Tumor Necrosis Factor-alpha